Suchergebnisse - "DENG YIJUN"

PubPharm (167)

71

Correction to : Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial

enthalten in: Critical care (London, England) | 2022

von Ke, L. | Lin, J. | Doig, G. | +192

ErratumFor: Crit Care. 2022 Feb 16;26(1):46. - PMID 35172856

72

Correction to: Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial

enthalten in: Critical care | 2022

von Ke, L. | Lin, J. | Doig, G. | +95

73

Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection

enthalten in: Journal of virology | 2022

von Zhang, Y. | Yan, Q. | Luo, K. | +18

74

Actively implementing an evidence-based feeding guideline for critically ill patients (NEED) : a multicenter, cluster-randomized, controlled trial

enthalten in: Critical care (London, England) | 2022

von Ke, L. | Lin, J. | Doig, G. | +192

ErratumIn: Crit Care. 2022 Apr 21;26(1):115. - PMID 35449019

75

Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial

enthalten in: Critical care | 2022

von Ke, L. | Lin, J. | Doig, G. | +95

76

NITROXOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von WU LIANG | DENG YIJUN | XIAO LU | +1

77

SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von BURNS CHRISTOPHER J | ROSEN LAWRENCE | CONDON STEPHEN M | +6

78

Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation

enthalten in: Frontiers in immunology | 2022

von Ma, J. | Cheng, Z. | Xue, M. | +15

79

PREPARATION METHOD FOR AROMATIC ETHER COMPOUND

enthalten in: Europäisches Patentamt | 2021

von WU LIANG | ZHOU CHEN | DENG YIJUN

80

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

enthalten in: Emerging microbes & infections | 2021

von Yan, Q. | He, P. | Huang, X. | +21